BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38105147)

  • 1. Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosis.
    Schleicher EM; Kaps L; Schattenberg JM; Galle PR; Wörns MA; Gairing SJ; Labenz C
    Dig Liver Dis; 2024 Jun; 56(6):1046-1053. PubMed ID: 38105147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis.
    Ballester MP; Tranah TH; Balcar L; Fiorillo A; Ampuero J; Kerbert AJC; Thomsen KL; Escudero MD; Mandorfer M; Reiberger T; Shawcross DL; Romero-Gómez M; Montoliu C; Carbonell-Asins JA; Jalan R
    J Hepatol; 2023 Oct; 79(4):967-976. PubMed ID: 37277075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.
    Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Clin Transl Gastroenterol; 2020 Jun; 11(6):e00172. PubMed ID: 32568474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis.
    Ney M; Tangri N; Dobbs B; Bajaj J; Rolfson D; Ma M; Ferguson T; Bhardwaj P; Bailey RJ; Abraldes J; Tandon P
    Am J Gastroenterol; 2018 Oct; 113(10):1506-1515. PubMed ID: 30267028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization.
    Patidar KR; Thacker LR; Wade JB; Sterling RK; Sanyal AJ; Siddiqui MS; Matherly SC; Stravitz RT; Puri P; Luketic VA; Fuchs M; White MB; Noble NA; Unser AB; Gilles H; Heuman DM; Bajaj JS
    Am J Gastroenterol; 2014 Nov; 109(11):1757-63. PubMed ID: 25178701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal naming test is a simple and valid tool for detecting covert hepatic encephalopathy and predicting outcomes in Chinese-speaking regions: a preliminary study.
    Huang CH; Yu TY; Tseng WJ; Huang YT; Chang SH; Hsieh SY; Chien RN; Amodio P
    Ann Med; 2023 Dec; 55(1):2236013. PubMed ID: 37494454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosis.
    Labenz C; Nagel M; Toenges G; Kuchen R; Schattenberg JM; Hilscher M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Eur J Intern Med; 2020 Dec; 82():83-89. PubMed ID: 32873457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Handgrip strength stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis.
    Miwa T; Hanai T; Nishimura K; Maeda T; Ogiso Y; Imai K; Suetsugu A; Takai K; Shiraki M; Shimizu M
    JPEN J Parenter Enteral Nutr; 2022 May; 46(4):858-866. PubMed ID: 34287991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver Cirrhosis.
    Schleicher EM; Kremer WM; Kalampoka V; Gairing SJ; Kaps L; Schattenberg JM; Galle PR; Wörns MA; Nagel M; Weinmann-Menke J; Labenz C
    Clin Transl Gastroenterol; 2022 Jul; 13(7):e00512. PubMed ID: 35905416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival.
    Gairing SJ; Mangini C; Zarantonello L; Gioia S; Nielsen EJ; Danneberg S; Lok AS; Sultanik P; Galle PR; Labenz J; Thabut D; Marquardt JU; Bloom PP; Lauridsen MM; Montagnese S; Nardelli S; Labenz C
    J Intern Med; 2024 Mar; 295(3):331-345. PubMed ID: 37983845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients.
    Wang AJ; Peng AP; Li BM; Gan N; Pei L; Zheng XL; Hong JB; Xiao HY; Zhong JW; Zhu X
    World J Gastroenterol; 2017 Sep; 23(34):6321-6329. PubMed ID: 28974899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple covert hepatic encephalopathy screening model based on blood biochemical parameters in patients with cirrhosis.
    Miwa T; Hanai T; Nishimura K; Maeda T; Tajirika S; Imai K; Suetsugu A; Takai K; Yamamoto M; Shimizu M
    PLoS One; 2022; 17(11):e0277829. PubMed ID: 36449492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing.
    Duarte-Rojo A; Allampati S; Thacker LR; Flud CR; Patidar KR; White MB; Klair JS; Heuman DM; Wade JB; Gavis EA; Bajaj JS
    Metab Brain Dis; 2019 Feb; 34(1):289-295. PubMed ID: 30506333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in patients with compensated and decompensated liver cirrhosis.
    Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Galle PR; Wörns MA
    Eur J Intern Med; 2019 Dec; 70():54-59. PubMed ID: 31530418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale.
    Tandon P; Tangri N; Thomas L; Zenith L; Shaikh T; Carbonneau M; Ma M; Bailey RJ; Jayakumar S; Burak KW; Abraldes JG; Brisebois A; Ferguson T; Majumdar SR
    Am J Gastroenterol; 2016 Dec; 111(12):1759-1767. PubMed ID: 27481305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis.
    Hanai T; Nishimura K; Miwa T; Maeda T; Nakahata Y; Imai K; Suetsugu A; Takai K; Shimizu M
    J Gastroenterol; 2022 Dec; 57(12):981-989. PubMed ID: 36173512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Post-Traumatic Stress Disorder on Cognitive Function and Covert Hepatic Encephalopathy Diagnosis in Cirrhotic Veterans.
    Burroughs TK; Wade JB; Ellwood MS; Fagan A; Heuman DM; Fuchs M; Bajaj JS
    Dig Dis Sci; 2018 Feb; 63(2):481-485. PubMed ID: 29313245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covert hepatic encephalopathy is associated with aggressive disease progression and poor survival in patients with cirrhosis.
    Wang J; Deng MJ; Shi PM; Peng Y; Wang XH; Tan W; Wang PQ; Chen YX; Yuan ZL; Ning BF; Xie WF; Yin C
    J Dig Dis; 2023 Dec; 24(12):681-690. PubMed ID: 38108656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis.
    Labenz C; Toenges G; Huber Y; Nagel M; Marquardt JU; Schattenberg JM; Galle PR; Labenz J; Wörns MA
    Am J Gastroenterol; 2019 May; 114(5):764-770. PubMed ID: 30848730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.